Ikegami H, Sumiyoshi T, Ishizuka N, Ueda M, Inaba T, Hosoda S, Aomi S, Endo M, Hashimoto A, Koyanagi H
Department of Cardiology, Tokyo Women's Medical College, Japan.
Nihon Kyobu Geka Gakkai Zasshi. 1995 Oct;43(10):1720-9.
Increases in pancreatic enzyme levels after cardiovascular surgery were studied, and their clinical characteristics evaluated. The subjects were 128 patients who had undergone cardiovascular surgery (65 patients after valve replacement, 32 after coronary bypass surgery and 31 after aortic artificial graft replacement). The pancreatic enzyme (serum amylase and lypase) levels were monitored serially before and after operation, and amylase fractions were measured at their peaks. The relationships of the peak lypase level with underlying cardiac diseases, background factors, factors related to surgery, factors related to the extracorporeal circulation, presence or absence of symptoms, and treatments were examined. The amylase level exhibited biphasic changes consisting of a peak in which salivary glands amylase (S type) was dominant and a peak in which pancreatic amylase (P type) was dominant. The second peak coincided with the peak lypase and occurred mostly 3 to 10 days after operation. The peak lypase level exceeded the normal range in 78% of all the patients. It exceeded 564 U/l, 4 times the normal value in 28% of the patients, many of whom were symptomatic. So, we recommended that these cases should be treated as "postoperative pancreatitis". A high peak lypase level showed a significant correlation with the history of gallbladder and pancreatic diseases and diabetes mellitus among the background factors and emergency operation and the use of IABP among the surgery-related factors.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了心血管手术后胰腺酶水平的升高情况,并评估了其临床特征。研究对象为128例行心血管手术的患者(65例瓣膜置换术后,32例冠状动脉搭桥术后,31例主动脉人工血管置换术后)。连续监测手术前后的胰腺酶(血清淀粉酶和脂肪酶)水平,并在峰值时测定淀粉酶组分。研究了脂肪酶峰值水平与基础心脏疾病、背景因素、手术相关因素、体外循环相关因素、症状的有无及治疗之间的关系。淀粉酶水平呈现双相变化,包括以唾液腺淀粉酶(S型)为主的峰值和以胰腺淀粉酶(P型)为主的峰值。第二个峰值与脂肪酶峰值一致,大多发生在术后3至10天。所有患者中78%的脂肪酶峰值水平超过正常范围。28%的患者超过564 U/l,为正常值的4倍,其中许多患者有症状。因此,我们建议将这些病例视为“术后胰腺炎”进行治疗。脂肪酶峰值水平高与背景因素中的胆囊和胰腺疾病史及糖尿病,以及手术相关因素中的急诊手术和主动脉内球囊反搏的使用显著相关。(摘要截选至250字)